Prucalopride for the treatment of chronic constipation in women
National Institute for Health and Clinical Excellence
Record ID 32011000055
English
Authors' recommendations:
Prucalopride is recommended as an option for the treatment of chronic constipation only in women for whom treatment with at least two laxatives from different classes, at the highest tolerated recommended doses for at least 6 months, has failed to provide adequate relief and invasive treatment for constipation is being considered.If treatment with prucalopride is not effective after 4 weeks, the woman should be re-examined and the benefit of continuing treatment reconsidered.Prucalopride should only be prescribed by a clinician with experience of treating chronic constipation, who has carefully reviewed the woman’s previous courses of laxative treatments specified above.
Details
Project Status:
Completed
URL for project:
http://www.nice.org.uk/nicemedia/live/13284/52078/52078.pdf
Year Published:
2010
URL for published report:
http://www.nice.org.uk/TA211
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England
MeSH Terms
- Benzofurans
- Chronic Disease
- Constipation
- Laxatives
- Serotonin Receptor Agonists
- Women
Contact
Organisation Name:
National Institute for Health and Care Excellence
Contact Address:
Level 1A, City Tower, Piccadilly Plaza, Manchester, M1 4BT
Contact Name:
nice@nice.nhs.uk
Contact Email:
nice@nice.nhs.uk
Copyright:
National Institute for Health and Clinical Excellence (NICE)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.